Whitehawk Therapeutics (WHWK) Other Operating Expenses (2019 - 2026)
Whitehawk Therapeutics (WHWK) posted quarterly Other Operating Expenses of -$177000.0 for Q3 2025, down 100.2% quarter-over-quarter from $87.4 million in Q1 2025.
Whitehawk Therapeutics (WHWK) Other Operating Expenses (2019 - 2026) Analysis & Trends
Whitehawk Therapeutics (WHWK) has reported Other Operating Expenses for 5 consecutive years, with -$177000.0 the latest figure, recorded in Q3 2025.
- In Q3 2025, Other Operating Expenses changed N/A year-over-year to -$177000.0; the TTM figure through Mar 2026 stood at -$177000.0 (down 100.2% YoY), while the FY2025 annual figure was $87.3 million, changed N/A from the prior year.
- Other Operating Expenses retreated to -$177000.0 in Q3 2025 per WHWK's latest filing, from $87.4 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at $87.4 million in Q1 2025 and bottomed at -$177000.0 in Q3 2025.
- Historically, Other Operating Expenses has averaged $15.4 million across 4 years, with a median of $656000.0 in 2023.
- Annual changes were most pronounced in 2022 — Other Operating Expenses tumbled 99.2% — and 2023, when it jumped 317.57%.
- Whitehawk Therapeutics' Other Operating Expenses stood at $74.2 million in 2021, then plunged by 99.7% to $222000.0 in 2022, then jumped by 317.57% to $927000.0 in 2023, then slumped by 119.09% to -$177000.0 in 2025.
- Business Quant data shows WHWK's Other Operating Expenses at -$177000.0 in Q3 2025, $87.4 million in Q1 2025, and $927000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Whitehawk Therapeutics | 369.67 Mn | 74.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 87.40 Mn |
| Sep 30, 2025 | -177,000.00 |
| Mar 31, 2025 | 87.44 Mn |
| Dec 31, 2023 | 927,000.00 |
| Sep 30, 2023 | 697,000.00 |
| Jun 30, 2023 | 656,000.00 |
| Mar 31, 2023 | 529,000.00 |
| Dec 31, 2022 | 222,000.00 |
| Sep 30, 2022 | 593,000.00 |
| Jun 30, 2022 | 4.07 Mn |
| Mar 31, 2022 | 179,000.00 |
| Sep 30, 2021 | 74.16 Mn |
| Dec 31, 2019 | 987,210.00 |
| Jun 30, 2019 | 915,094.00 |